Caroline Walkinshaw and Jacquelyn Bonnell named to key global and regional senior roles

Data Supported Initiation of Currently Enrolling Pivotal Phase 3 ADMIRAL Trial

The challenge is open to nearly anyone with a tangible, unique idea to improve cancer care

Employees also raised nearly $60K at Second Annual “One Astellas Spirit Run”

- Amendment accelerates anticipated PROSPER top-line results by two years -

-Pivotal Monotherapy Phase 2 Trial Initiation Planned for 2017-

- Decision follows recommendation of Independent Data Monitoring Committee -

Astellas Americas President Jim Robinson to discuss the importance of listening to patients in tackling health decision-making, financial burden and transparency in care

Long recognized for her impact in marketing and communications throughout the biopharma industry.

- Acquisition Expands Astellas' Late Stage Clinical Pipeline with Fezolinetant -